NEWSROOM

biopharmaceutical

PAOG Confirms Plans For First CBD Nutraceutical Revenue In 2021 Targeting $16 Billion Market

  Sandusky, OH, Sept. 17, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today published a brief status update on the company’s ongoing initiatives to include confirming plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021. The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027. PAOG plans to...

read more

Galexxy Holdings Inc. Announces its Genus CBD Brand

Newport Beach, California, Sept. 01, 2021 -- McapMediaWire -- Galexxy Holdings Inc. (formerly Agtech) [OTC Pink: AGGL] is pleased to announce that its Genus™ CBD product brand soon to be launched by Galexxy Corporation, has been successfully trademarked. The term “Genus” is borrowed from Latin, and it is a biological classification, ranking between a plant family and species. As a wholly-owned subsidiary, Galexxy Corporation will market Genus™ CBD products online direct to consumers, using its...

read more

Link Reservations Inc/LinkResPet (LRSV) Expands Retail Presence in Florida as Products Now Stocked in All 4 Collins Tobacco & Vape Shops

  London, UK, August 16, 2021 – McapMediaWire -- Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets, announces its LinkResPet and DailyLifeCBD products will be available for purchase in all four retail locations of Collins Tobacco & Vape Stores. This comes as the Company looks to expand its presence across the marketplace and increase consumer awareness of its pet and human wellness...

read more

Link Reservations Inc./LinkResPet (LRSV) Preparing to Launch Its 2nd Mushroom Wellness Product Aimed At Stress & Anxiety For People

  London, UK, July 29, 2021 - McapMediaWire - Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets, announces it is preparing to develop & launch its second functional mushroom product via its subsidiary DailyLife CBD. The new tincture product, tailored for people, will feature both CBD and a wide spectrum of functional mushrooms (including Lion’s Mane & Shiitake) which...

read more

Nutra Pharma Provides Business and Compliance Updates

  Nutra Pharma is providing updates regarding their business plans, accounting and compliance   Plantation, Florida, July 26, 2021 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their...

read more

Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures

  Nutra Pharma has filed an updated provisional patent for the protection of their intellectual property surrounding the use of RPI-78M and analogs of the drug as potential counter-measures against organophosphate nerve agents   Plantation, Florida, July 23, 2021 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is...

read more

Nutra Pharma Engages Government Affairs Consulting Firm

  Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies   Plantation, Florida, July 15, 2021 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing...

read more

PAOG Confirms CBD Nutraceuticals Business Development Update To Include ALKM, USMJ and PURA Highlights Scheduled This Wednesday, June 23rd

  Sandusky, OH, June 21, 2021 – McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceuticals Business Development Update scheduled for release this week, on Wednesday, June 23rd, 2021. PAOG plans to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021, is on track.  The company also continues in the long-term CBD pharmaceutical. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to...

read more

PAOG CBD Nutraceuticals Rollout On Track Targeting $5 Billon Market

  Sandusky, OH, June 17, 2021 –  McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the company’s plan to launch a CBD Nutraceuticals line of products expected to generate revenue this year, in 2021, is on track.  The company also continues in the long-term CBD pharmaceutical. Next week, on Wednesday, June 23rd, management will release an update on the company’s CBD Nutraceuticals development initiative to include new developments expected to expand PAOG’s overall market...

read more

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin® line of pain relief products to their marketplace Plantation, Florida, June 8, 2021 — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet, and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...

read more

Categories